UPClytics
Alle Fälle anzeigen

UPC CoA 2/2024

2. Jan. 2024·EP3763331 · PROSTHETIC VALVE CRIMPING DEVICE

Verfahrensdetails
Status
Case Closed
Verfahrensart
Berufung
Kategorie
Hauptberufung
Parteien
Kläger
Vertreter
Beklagte
Vertreter
Division
Court of Appeal
Technologie
  • Instruments
    Medical technology
  • Mechanical engineering
    Machine tools
Sprache
German
Erste Entscheidung
15. Feb. 2024
EPA-Einspruch
Im Vergleich
Wie lange das Gericht bis zu einer ersten Entscheidung braucht.
Median Tage bis zur ersten Entscheidung
Gesamt-UPC124
Richter Klaus GrabinskiGesperrt
Richter Peter BlokGesperrt
Richter Emanuela GermanoGesperrt
Richter Bernard LedeboerGesperrt
Richter Stefan WilhelmGesperrt

Vor dem UPC: Meril Group (60 Verfahren)·Edwards Lifesciences Group (57 Verfahren)

Dieser Streit umfasst 2 weitere Verfahren

UPC APP 3187/2024·UPC CFI 249/2023

1 weitere Beklagte zum selben oder einem verwandten Patent

UPC CoA 4/2024

Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.

Weitere Verfahren: Court of Appeal·2024

Entscheidungen
  • 2024-10-04
    Appeal RoP220.2Öffentlich

    Zusammenfassung: Order from the Court of Appeal dated 4 October 2024 on costs following Meril's submission of an undertaking (Unterlassungs- und Verpflichtungserklärung) to Edwards Lifesciences, which resulted in dismissal of the preliminary injunction action. The CoA held that, where a defendant undertakes to comply with the claimant's requests after proceedings have commenced, the claimant is generally to be regarded as the prevailing party under Art. 69(1) UPCA, without any need to examine the merits at the time of the undertaking. The undertaking itself implies that the claimant's requests were satisfied. Accordingly, Meril was ordered to bear the costs of proceedings.

    Rechtsfragen anzeigen (2)
    • Prevailing party determination after undertaking under Art. 69(1) UPCA
    • Costs allocation after dismissal following defendant's undertaking
  • 2024-02-15

    Zusammenfassung: Procedural order of the Court of Appeal addressing the appeal fee in an appeal by Meril GmbH and Meril Life Sciences against a Munich Local Division order in provisional measures proceedings brought by Edwards Lifesciences Corporation regarding EP 3 763 331 (crimping device for heart valve prostheses). After Meril submitted a cease-and-desist undertaking, Edwards accepted it and the case was resolved without a ruling. The first-instance court ordered Meril to bear costs up to EUR 200,000 and set the action value at EUR 1,500,000. Meril appealed. The Court of Appeal order concerned procedural aspects of the appeal fee payment.

    Rechtsfragen anzeigen (3)
    • Appeal fee in provisional measures proceedings
    • Costs after cease-and-desist undertaking rendering action devoid of purpose
    • Devolution of costs on acceptance of cease-and-desist undertaking
DokumenttitelDatumÖffentlich
Acknowledgement-of-lodging2024-10-14Nicht öffentlich
Application - Change of Address2024-10-14Nicht öffentlich
Acknowledgement-of-lodging2024-10-04Nicht öffentlich
Headnote-and-Keywords2024-10-04Nicht öffentlich
Decision-On-Appeal-On-Measures-Outcome2024-10-04Nicht öffentlich
Final order2024-10-04Öffentlich
Hearing reference2024-07-22Nicht öffentlich
Hearing reference2024-07-22Nicht öffentlich
Receipt2024-07-11Nicht öffentlich
Anlage HLB 52024-07-10Nicht öffentlich